The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...

Fish delivers protein, and when you choose a fatty fish like tuna, salmon or trout, you're also getting omega-3 fatty acids. Omega-3 fats may help reduce fat levels (triglycerides) in the blood and ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

When waste builds up in your system because your kidneys aren’t filtering it out, it can start to mess with other parts of ...

Various foods, such as berries, whole grains, fish, milk, and some plant-based options, have shown anti-diabetic effects in studies. These foods are rich in bioactive compounds that may assist in ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is initiating a Phase 1 clinical study titled A PHASE 1, ...

Dr. Ambish Mithal unpacks the world of new-age weight management drugs, their side effects, their benefits and what lies ...

Cardiovascular disease is the leading cause of morbidity and mortality in patients with end-stage kidney disease. Currently, thrice-weekly in-center hemodialysis for 3 to 5 hours per session is the ...